Study of Oral Clofarabine Administered Daily for 5 Days in Adult Patients With Refractory Solid Tumors
This study has been completed.
Sponsor:
Genzyme
Information provided by:
Genzyme
ClinicalTrials.gov Identifier:
NCT00125827
First received: July 29, 2005
Last updated: September 16, 2008
Last verified: June 2007
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | February 2006 |
| Primary Completion Date: | October 2004 (Final data collection date for primary outcome measure) |